A novel mutation c.2010delG of CLCN5 gene associated with Dent disease-1 in an 11-year-old male with nephrolithiasis and nephrocalcinosis
https://doi.org/10.21508/1027-4065-2018-63-2-70-72
Abstract
RETRACTED
Dent’s disease-1 (CLCN5 gene) is a rare X-linked recessive tubulopathy characterized by low molecular weight proteinuria, hypercalciuria, nephrolcalcinosis or nephrolithiasis, proximal tubular dysfunction and renal failure in adulthood. Females are carriers and usually mildly affected. We present an 11-year-old child with nephrocalcinosis and nephrolithiasis with c.2010delG (or p.Asp671fs) mutation in CLCN5 gene which had not previously been reported in the Dent’s disease-1.
About the Authors
B. KuluTurkey
O. Sancakli
Turkey
O. Sakallioglu
Turkey
Doc. Dr. Department of Pediatrics
References
1. Wrong O. Nephrocalcinosis. In: Oxford Textbook of Clinical Nephrology. A. Davison, J. Cameron, J. Grünfeld (eds).
2. Oxford, Oxford University Press 2005; 1375.
3. Ludwig M., Utsch B., Monnens L. Recent advances in understanding the clinical and genetic heterogeneity of Dent’s disease. Nephrol Dial Transplant 2006; 21: 2708–2717. DOI: 10.1093/ndt/gfl346
4. Thakker R. Pathogenesis of Dent’s disease and related syndromes of X-linked nephrolithiasis. Kidney Int 2000; 57: 787–793.
5. Bockenhauer D., Bokenkamp A., Nuutinen M., Unwin R., Van’t Hoff W., Sirimanna T., Vrljicak K., Ludwig M. Novel OCRL mutations in patients with Dent-2 disease. J Pediatr Genet 2012; 1: 15–23. DOI: 10.3233/PGE-2012–005
6. Ludwig M., Utsch B., Balluch B., Fründ S., Kuwertz-Bröking E., Bökenkamp A. Hypercalciuria in patients with CLCN5 mutations. Pediatr Nephrol 2006; 21: 1241–1250. DOI: 10.1007/s00467-006-0172-9
7. Hoopes R.Jr., Raja K., Koich A., Hueber P., Reid R., Knohl S.J., Scheinman S.J. Evidence for genetic heterogeneity in Dent’s disease. Kidney Int 2004; 65: 1615–1620. DOI: 10.1111/j.1523–1755.2004.00571.x
8. Edvardsson V., Goldfarb D., Lieske J Beara-Lasic L., Anglani F., Milliner D.S., Palsson R. Hereditary causes of kidney stones and chronic kidney disease. Pediatr Nephrol 2013; 28: 1923–1942. DOI: 10.1007/s00467-012-2329-z
9. Devuyst O., Thakker R. Dent’s disease. Orphanet J Rare Dis 2010; 5: 28. DOI: 10.1186/1750-1172-5-28
10. Scheinman S. X-linked hypercalciuric nephrolithiasis: clinical syndromes and chloride channel mutations. Kidney Int 1998; 53: 3–17.
11. Raja K., Schurman S., D’mello R.. Blowey D., Goodyer P., Van Why S., Ploutz-Snyder R.J., Asplin J., Scheinman S.J. Responsiveness of hypercalciuria to thiazide in Dent’s disease. J Am Soc Nephrol 2002; 13: 2938–2944.
12. Blanchard A., Vargas-Poussou R., Peyrard S., Mogenet A., Baudouin V., Boudailliez B., Charbit M. et al. Effect of hydrochlorothiazide on urinary calcium excretion in Dent disease: an uncontrolled trial. Am J Kidney Dis 2008; 52: 1084– 1095. DOI: 10.1053/j.ajkd.2008.08.021
Review
For citations:
Kulu B., Sancakli O., Sakallioglu O. A novel mutation c.2010delG of CLCN5 gene associated with Dent disease-1 in an 11-year-old male with nephrolithiasis and nephrocalcinosis. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2018;63(2):70-72. https://doi.org/10.21508/1027-4065-2018-63-2-70-72